Showing results (71-80 of 2,878) with videos related to
Sort By:
Pageof 288
Current Pharmaceutical Design|July 23, 2003
The prothrombotic state in hypertension and the effects of antihypertensive treatmentSunil Nadar, Gregory Y H LipAmerican Journal of Hypertension|February 16, 2017
Malignant Hypertension Revisited-Does This Still Exist?Alena Shantsila, Gregory Y H LipCardiac Electrophysiology Review|May 27, 2003
Ethnicity and arrhythmiasBethan Freestone, Gregory Y H LipExpert Opinion on Pharmacotherapy|December 4, 2010
Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practiceBurak Pamukcu, Gregory Y H LipCurrent Hypertension Reports|April 3, 2012
Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?Vadim Tchaikovski, Gregory Y H LipClinical Medicine Insights. Cardiology|March 13, 2012
Stroke Prevention in Atrial Fibrillation: Where are We Now?Yousif Ahmad, Gregory Y H LipExpert Opinion on Investigational Drugs|June 24, 2004
Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utilityAnirban Choudhury, Gregory Y H LipSeminars in Vascular Medicine|August 27, 2005
Ximelagatran in the clinic: practical management of patientsSam Schulman, Gregory Y H LipEuropean Heart Journal|May 10, 2014
Edoxaban: a focused review of its clinical pharmacologyGregory Y H Lip, Giancarlo AgnelliThrombosis and Haemostasis|February 19, 2008
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness dataMichael Hughes, Gregory Y H Lip, Pageof 288